C4 Therapeutics, Inc. CCCC

$2.98 -1.65% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-09-25 View →
4 FORM 4 2026-09-21 View →
10-Q 10-Q 2026-08-11 View →
8-K 8-K 2026-08-11 View →
4 FORM 4 2026-07-13 View →
4 FORM 4 2026-07-02 View →
4 FORM 4 2026-07-02 View →
4 FORM 4 2026-06-26 View →
4 FORM 4 2026-06-26 View →
4 FORM 4 2026-06-26 View →
4 FORM 4 2026-06-26 View →
4 FORM 4 2026-06-26 View →
4 FORM 4 2026-06-26 View →
4 FORM 4 2026-06-26 View →
4 FORM 4 2026-06-26 View →
8-K 8-K 2026-06-24 View →
8-K 8-K 2026-06-11 View →
4 FORM 4 2026-06-04 View →
8-K 8-K 2026-05-15 View →
10-Q 10-Q 2026-05-12 View →
8-K 8-K 2026-05-12 View →
DEF 14A DEF 14A 2026-04-29 View →
8-K 8-K 2026-04-10 View →
8-K 8-K 2026-04-09 View →
4 FORM 4 2026-04-03 View →
4 FORM 4 2026-04-03 View →
10-K 10-K 2026-02-26 View →
8-K 8-K 2026-02-26 View →
4 FORM 4 2026-02-18 View →
4 FORM 4 2026-02-18 View →
4 FORM 4 2026-02-18 View →
4 FORM 4 2026-02-18 View →
4 FORM 4 2026-02-18 View →
4 FORM 4 2026-02-18 View →
4 FORM 4 2026-02-18 View →
4 FORM 4 2026-01-16 View →
8-K 8-K 2026-01-14 View →
4 FORM 4 2026-01-05 View →
4 FORM 4 2026-01-05 View →
424B5 424B5 2025-12-10 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$2.98
Market Cap
$366.61 million
52-Week Range
$1.69 – $5.17
Average Volume
2.16 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.